HCPCS Level II J0573: Buprenorphine/Naloxone Oral 3–6 mg Buprenorphine
HCPCS Level II code J0573 represents dispensed oral buprenorphine/naloxone formulation containing more than 3 mg up to and including 6 mg of buprenorphine; this code is used for billing medication administration or pharmacy dispensing of a combined opioid partial agonist/antagonist used in opioid use disorder treatment or medically supervised opioid withdrawal, typically recorded as a pharmacy or outpatient medication service and commonly provided in ambulatory clinics, outpatient addiction treatment centers, and pharmacy dispensing settings.
For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only), Antibody-Drug Conjugates.
Customize your policy alerts
Sign up for hcpcs J0573 policy alerts
Get alerted when payer policies referencing J0573 are released or updated.
Monitor payer policy activity